MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/hc9.0000000000000876

Медицинская библиотека · Hepatology communications · 2026

Hepatitis B treatment response and factors associated with HBV treatment success: A population-based study in Rwanda.

Makuza Jean Damascene, Law Michael, Ramji Alnoor, Jeong Dahn, Puyat Joseph, Aravindakshan Atul, Morrow Richard L, Adu Prince Asumadu, Nisingizwe Marie Paul, Cua Georgine, Velásquez García Héctor Alexander, Berabose Charles, Tuyishime Albert, Janjua Naveed Zafar

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Timely treatment of chronic hepatitis B virus (HBV) infection reduces complications such as cirrhosis and hepatocellular carcinoma and improves overall survival. In Sub-Saharan Africa, data on HBV treatment success are limited, especially among people living with HBV mono-infection. We assessed the success of HBV treatment and associated factors among people diagnosed with HBV mono-infection and HIV co-infection.

METHODS

We used data from the District Health Information System 2 in Rwanda, covering 4.6 million screened individuals (January 2016-June 2023). Patients receiving HBV therapy for ≥12 months were included. Treatment success was defined as undetectable HBV DNA or normal ALT at 12 months. We used multilevel logistic regression to assess risk factors, accounting for clustering by hospital.

RESULTS

Among 4733 treated individuals (median age: 39 y, 58.4% male), 4518 (95.5%) achieved treatment success, increasing over time (90.3% for <2 y vs. 95.8% for ≥2 y of follow-up). Treatment success was mostly assessed by ALT normalization (87.5%). HBV mono-infected and HBV/HIV co-infected individuals had similar overall treatment success rates [3730 (95.5%) vs. 788 (95.2%)]. However, among those treated for <2 years, success was lower in HBV/HIV individuals [7 (43.8%) vs. 283 (92.7%)]. In multivariable analysis, HCV co-infection (aOR: 0.33; 95% CI: 0.12, 0.85), follow-up at provincial/referral hospitals (aOR: 0.26; 95% CI: 0.08, 0.86), and cirrhosis (aOR: 0.36; 95% CI: 0.20, 0.63) were associated with a lower likelihood of HBV treatment success.

CONCLUSIONS

HBV treatment success in Rwanda was high but lower in those with HBV/HCV co-infection or cirrhosis, underscoring the need for early detection and monitoring.

Для цитирования: Makuza Jean Damascene, Law Michael, Ramji Alnoor, Jeong Dahn, Puyat Joseph, Aravindakshan Atul, Morrow Richard L, Adu Prince Asumadu, Nisingizwe Marie Paul, Cua Georgine, Velásquez García Héctor Alexander, Berabose Charles, Tuyishime Albert, Janjua Naveed Zafar. Hepatitis B treatment response and factors associated with HBV treatment success: A population-based study in Rwanda.. Hepatology communications. 2026. DOI: 10.1097/hc9.0000000000000876.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.